Company Filing History:
Years Active: 2015
Title: Victoria Mary Perreau: Innovator in Neuropathological Disease Detection
Introduction
Victoria Mary Perreau is a notable inventor based in Parkville, Australia. She has made significant contributions to the field of neuropathological disease detection through her innovative research and patented methods. Her work focuses on the detection and modulation of diseases such as multiple sclerosis and other inflammatory neural disorders.
Latest Patents
Victoria holds a patent titled "TAM receptors and TAM receptor ligands in detection and modulation of neuropathological disease." This patent encompasses methods, compositions, and kits based on TAM receptors or TAM receptor ligands. These innovations are designed for the detection of neuropathological diseases and the determination of their progression. The methods include screening cells from subjects, where an elevation in the expression of a TAM receptor or a change in the expression of a TAM receptor ligand indicates the presence or progression of the disease. Furthermore, subjects with such diseases can be treated by administering TAM receptor ligands, such as GAS 6 or Protein S, or by using agonists like antibodies specific for the TAM receptors Axl, Mer, or Tyro3.
Career Highlights
Victoria is affiliated with the Howard Florey Institute, where she continues her research and development in the field of neuropathology. Her work has garnered attention for its potential impact on the diagnosis and treatment of debilitating neural diseases.
Collaborations
Victoria has collaborated with esteemed colleagues, including Judith Field and Michele D Binder, to advance her research and contribute to the scientific community.
Conclusion
Victoria Mary Perreau is a pioneering inventor whose work in neuropathological disease detection is making a significant difference in the field. Her innovative approaches and patented methods hold promise for improving the diagnosis and treatment of various neural disorders.